Condition (MeSH)
Herpes Zoster Ophthalmicus
ClinicalTrials.gov lists 1 trial for Herpes Zoster Ophthalmicus or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Rows recorded per section
4 sections measured, none recorded · 1 not measured yet · 1 not computed
1 of the 1 trial is tagged with Herpes Zoster Ophthalmicus itself; the rest are tagged with a narrower condition beneath it.
When did Herpes Zoster Ophthalmicus trials start? (1)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
| Year | Trials started |
|---|---|
| 2017 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 1 trial evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Herpes Zoster Ophthalmicus trials in? (1)
Shown in this order: phase order.
| Phase | Trials |
|---|---|
| Phase 4 | 1 |
How many Herpes Zoster Ophthalmicus trials are recruiting? (1)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which serious adverse events do Herpes Zoster Ophthalmicus trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| COVID-19 Infection | 4 | 1 |
| Chest Pain | 3 | 1 |
| Basal Cell Carcinoma | 2 | 1 |
| Breast Cancer | 2 | 1 |
| Crohn's Flare | 2 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Herpes Zoster Ophthalmicus? (16)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Low-Dose Valacyclovir in Herpes Zoster Ophthalmicus: The Zoster Eye Disease Randomized Clinical Trial. | JAMA ophthalmology | 2025 | Yes |
| Low-Dose Valacyclovir for Postherpetic Neuralgia in the Zoster Eye Disease Study: A Randomized Clinical Trial. | JAMA ophthalmology | 2025 | Yes |
| Baseline Participant Characteristics at Enrollment in the Zoster Eye Disease Study. | Cornea | 2024 | Yes |
| Effectiveness of the live zoster vaccine during the 10 years following vaccination: real world cohort study using electronic health records. | BMJ (Clinical research ed.) | 2023 | Yes |
| Zoster Eye Disease Study: Rationale and Design. | Cornea | 2022 | Yes |
Showing 5 of 16 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.